A 6-month regimen for EPTB with intermittent treatment in the continuation phase: A study of 679 cases

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 8, 2005, Pages 890-895

  Caminero, José A ^a,b   Fuentes, Z M ^c   Martin T Y ^c   Espana M ^d   Isturiz G J ^c   Millán, E Avila ^c   Alfonzo, E ^c   Castillo, O Y ^c   Cabrera, P ^b   Guilarte, A ^d  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c Pneumology Department   (Venezuela)

^d Ministry of Health and Social Development   (Venezuela)

Author keywords

Extra pulmonary tuberculosis; Intermittent treatment; National Tuberculosis Programme; Short course treatment; Venezuela

Indexed keywords

ETHAMBUTOL; LIVER ENZYME; RIFATER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MILIARY TUBERCULOSIS; OBSERVATION; OSTEOARTHROPATHY; PRIORITY JOURNAL; RASH; RELAPSE; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENEZUELA; VISUAL DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; VENEZUELA;

EID: 23744442609     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003. Geneva, Switzerland: WHO, 2003.
2. International Union Against Tuberculosis and Lung Disease. Tuberculosis guide for low income countries; 5th ed. Paris, France: IUATLD, 2000.
3. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53: 536-548.
4. Horsburgh C R Jr, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. Guidelines from the infectious diseases society of America. Clin Infect Dis 2000; 31: 633-639.
5. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 107: 603-662.
6. Canadian Paediatric Society. Infectious diseases and immunisation committee. Short-course therapy for tuberculosis in infants and children. CMAJ 1994; 151: 912-913.
7. Donald P R, Schoeman J F, Van Zyl L E, De Villiers J N, Pretorius M, Springer P. Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis 1998; 2: 704-711.
8. Yuen A P W, Wong S H W, Tam C M, Chan S L, Wei W I, Lau S K. Prospective randomised study of the thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngol Head Neck Surg 1997; 116: 189-192.
9. British Thoracic Society Research Committee. Six-months versus nine-months chemotherapy for tuberculosis of lymph nodes: preliminary results. Respir Med 1992; 86: 15-19.
10. Campbell I A, Ormerod L P, Friend P A, Jenkins R, Prescott J. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results. Respir Med 1993; 87: 621-623.
11. Medical Research Council Working Party on Tuberculosis of the Spine. Five years assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Int Orthop 1999; 23: 73-81.
12. Medical Research Council Working Party on Tuberculosis of the Spine. A controlled trial of six-month and nine-month regimens of chemotherapy in patients undergoing radical surgery for tuberculosis of the spine in Hong Kong. Tubercle 1986; 67: 243-259.
13. Skutil V, Varsa J, Obsitnik M. Six-month chemotherapy for urogenital tuberculosis. Eur Urol 1985; 11: 170-176.
14. Jacobs R F, Sunakorn P, Chotpitavasunonah T, Pope S, Kelleher K. Intensive short course chemotherapy for tuberculous meningitis. Pediatr Infect Dis J 1992; 11: 194-198.
15. Van Loenhout-Rooyackers J H, Keyser A, Laheij R J F, Verbeek A L M, van der Mer J W M. Tuberculosis meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis 2001; 5: 1028-1035.
16. Cohn D L, Catlin B J, Peterson K L, Judson F N, Sbarbaro J A. A 62-dose, 6-month therapy for pulmonary and EPTB. A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990; 112: 407-415.
17. Lenk S, Schroeder J. Genitourinary tuberculosis. Curr Opin Urol 2001; 11: 93-98.
18. Fowler N O. Tuberculous pericarditis. JAMA 1991; 266: 99-103.
19. Galarza I, Canete C, Granados A, Estopa R, Manresa F. Randomised trial of corticosteroids in the treatment of tuberculous pleurisy. Thorax 1995; 50: 1305-1307.
20. Dutt A K, Moers D, Stead W W. Short-course chemotherapy for pleural tuberculosis. Nine years' experience in routine treatment service. Chest 1986; 90: 112-116.
21. Machado N, Grant C S, Scrimgeour E. Abdominal tuberculosis experience of a University hospital in Oman. Acta Trop 2001; 80: 187-190.
22. Moon M S, Moon Y W, Moon J L, Kim S S, Sun D H. Conservative treatment of tuberculosis of the lumbar and lumbosacral spine. Clin Orthop 2002; 398: 40-49.
23. Mert A, Bilir M, Tabak F, Ozaras R, Ozturk R. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology 2001; 6: 217-224.
24. Dutt A K, Moers D, Stead W W. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience. Ann Intern Med 1986; 104: 7-12.
25. Dutt A K, Stead W W. Treatment of extrapulmonary tuberculosis. Semin Respir Infect 1989; 4: 225-231.
26. Caminero J A. Tuberculosis extrapulmonar. Guía de la Tuberculosis para Médicos Especialistas. Paris, France: International Union Against Tuberculosis and Lung Disease, 2003.
27. Chaisson R E, Clermont H C, Holt E A, et al. Six month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med 1996; 154: 1034-1038.
28. Guilarte A. Programa Nacional de Tuberculosis. Acta Científica Venezolana 2001; 1: 2-4.
29. Dannenberg A, Tomashefki J. Pathogenesis of pulmonary tuberculosis. In Fishman A, ed. Pulmonary diseases and disorders. New York, NY: McGraw-Hill, 1988: pp 177-323.
30. Sheafer R W, Kim D S, Weiss J P. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70: 384-397.
31. Jawahar M S, Sivasubramanian S, Vijayan V K, et al. Short course chemotherapy for tuberculous lymphadenitis in children. BMJ 1990; 301: 359-362.
32. Cheung W L, Siu K F, Ng A. Six-month combination chemotherapy for cervical tuberculous lymphadenitis. J R Coll Surg Edinb 1992; 35: 293-295.